ATS 2024 Final Program

Click on the session title to view the speakers

SUNDAY • MAY 19

107

3:15 Transforming Asthma Management: Advancing Towards Precision Care With Spectral and Intra-breath Oscillometry 3:27 Are There Pulmonary Vascular Differences in GINA 4 and GINA 5 Asthma Severity? 3:39 Magnetic Resonance Imaging Ventilation Phenotypes of Severe Asthma 3:51 Quantitative CT and Computational Fluid Dynamics Cluster Analysis Discriminated Three Asthma Phenotypes 4:03 Spatial Profiling of Bronchial Airways in Asthma and COPD A101 FULL METAL JACKET TARGETING COPD AND CHRONIC AIRWAYS DISEASE 2:15 p.m. - 4:15 p.m. San Diego Convention Center Room 30C-E (Upper Level) Poster Viewing 2:15-3:00 Discussion 3:00-4:15 701 Fully Automated Mucus Plug Quantification on Chest CTs and Its Correlation With All-cause Mortality 702 Cross-sectional Analysis of Automated Mucus Plug Quantification and Airway Wall Thickness in COPD Using AI-based Detection 703 Tissue-resident Eosinophils Are Associated With Reduced Lung Function in Chronic Obstructive Pulmonary Disease 704 Improvements in Breathlessness, COPD Symptoms and Quality of Life Reported With Ensifentrine in a Pooled Analysis of the ENHANCE Trials 705 Tezepelumab in Adults With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD): Efficacy and Safety From the Phase 2a COURSE Study 706 Autoantibodies to Collagens Are Associated With Altered Lung Function and Increased Mortality Risk BASIC • CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION

707 The Role of DUOX1 in the Development of Cigarette Smoke-induced Emphysema and Pulmonary Hypertension 708 Mitochondrial Cytochrome C Oxidase Subunit 4 Isoform 2 Regulates T-cell Activation and Hyperinflammation During Virus-induced Exacerbation Following Smoke Exposure 709 Alveolar Matrix Metalloproteinases Transcripts Uniquely Contribute to Respiratory Morbidity Among PI*MZ Individuals in the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study 710 Whole-genome Sequencing Analyses of Imaging Phenotypes of Chronic Obstructive Pulmonary Disease 711 A Stop-gain in FUT2 Associates With Several COPD Related Phenotypes and Clinical Outcomes 712 Quantitative Computed Tomography Characteristics of Persistent Airflow Obstruction in Asthma Patients in the Severe Asthma Research Program 713 Healthcare Resource Utilization and Disease Burden in Chronic Obstructive Pulmonary Disease (COPD) Patients With Type 2 Inflammation in the United States: Real-world Evidence 714 Role of Monoclonal Antibodies in Patients With Eosinophilic Subtype COPD: A Meta-analysis of Randomized Controlled Trials 715 Inflammatory and Anti-inflammatory Effects of E-cigarette Aerosol Inhalation on Allergic Inflammatory Airways Disease in Mice 716 Identification of Protein Biomarkers Associated With Emphysema Progression 717 Multiple Event-time Analysis: A New Approach for Event Based Clinical Trials in Obstructive Airway Diseases 718 Activator Protein Transcription Factors Regulate Human IL-33 Expression and Splicing From Non-canonical Promoters in Chronic Airway Disease 719 Modulating Bronchial Vascular Remodeling in an Experimental Asthma-COPD Overlap Model Through IL-17 Inhibition

ATS 2024 Conference Program • San Diego, CA